HomeAI · summaries
Storia in 2 fonti
Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report - Merck & Co (NYSE:MRK), AbbVie
US lawmakers probe Merck and AbbVie over national security and ethical risks tied to clinical trials conducted in China.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report - Merck & Co (NYSE:MRK), AbbVie
US lawmakers probe Merck and AbbVie over national security and ethical risks tied to clinical trials conducted in China.
- ·
healio.com
US House committee opens investigations into five drugmakers over clinical trials in China
The U.S. House Select Committee on China has opened investigations into five pharmaceutical companies regarding their clinical trials in China, questioning whether the drugmakers…